Elena Cort\u00e9s Vicente (Castell\u00f3n, 1986) graduated in Medicine from the University of Valencia in 2010. She did her residency in Neurology at the Hospital de la Santa Creu i Sant Pau (2011-2015). In addition, she expanded her knowledge in clinical research through the Master’s Degree in Research Methodology in Health Sciences at the Universitat Aut\u00f2noma de Barcelona (2013-2016).<\/p>\n\n\n\n
For three months (2015) she worked in the laboratory of Dr. Michio Hirano at Columbia University (New York, USA) in the field of mitochondrial diseases.<\/p>\n\n\n\n
In 2015 she joined the Neuromuscular Unit as a clinical fellow and doctoral student. In 2016 she was awarded a Rio Hortega contract from the Carlos III Health Institute. In 2018, she defended her doctoral thesis entitled “New biomarkers of disease and prognosis in Myasthenia Gravis”, directed by Dr. Isabel Illa.<\/p>\n\n\n\n
From June 2018 to December 2019, she spent a stay as a post-doctoral researcher in the laboratory of Dr. Pere Santamaria at the University of Calgary (Canada), studying an innovative therapy for the treatment of autoimmune diseases. Her project focused on evaluating the efficacy of this new treatment in the pre-clinical model of Myasthenia Gravis. This stay was financed by a mobility grant for research staff hired within the framework of the AES (M-AES) and later by a grant from the Alfonso Mart\u00edn Escudero Foundation.<\/p>\n\n\n\n
Since 2020, she has been working as an associate neurologist and post-doctoral researcher at the Neuromuscular Diseases Unit thanks to the granting of a Juan Rod\u00e9s contract from the Carlos III Health Institute.<\/p>\n\n\n\n
Academic training:<\/strong><\/p>\n\n\n\n Scholarships and awards:<\/strong><\/p>\n\n\n\n\n
\n